Skip to content

Advertisement

Open Access

Nonirritant concentrations and amount of active ingredient in drug patch tests optimal concentrations for DPTs

  • Delphine Brajon1,
  • Sophie Menetre2,
  • Julie Waton1,
  • Claire Poreaux1 and
  • Annick Barbaud1
Clinical and Translational Allergy20144(Suppl 3):P1

https://doi.org/10.1186/2045-7022-4-S3-P1

Published: 18 July 2014

Keywords

DigoxinParacetamolActive IngredientActual ConcentrationAllergic Reaction

Background

Drug patch tests (DPTs) with medications suspected of causing an allergic reaction represent a method of diagnostic testing that is low risk, as DPTs can reproduce delayed hypersensitivity to drugs and entail only a moderate re-exposure of patients to potential offending drugs. We assessed the non-irritating concentration of DPTs to determine the amount of active ingredient (AI) contained in the drugs used in the tests.

Method

From a retrospective, single-center study of all patients treated during a 6-year period for etiological investigations following a drug eruption, each potentially responsible drug was tested from the commercially available preparation diluted to 30% of its concentration in water, petrolatum, or alcohol. Data collection was performed with a customized computer database. For each type of DPT studied, the numbers of positive and negative tests were recorded. The amount of AI contained in the DPT (as a percentage) was then calculated after weighing each tablet.

Results

Of the 5,558 DPTs studied, all were nonirritant. The average concentration of AI was 9.8%; 25% of DPTs had an AI concentration less than 2%, and 25% displayed an AI concentration above 16%. The AI concentration ranged from 0.05% (digoxin) to 30% (paracetamol lyophilisate).

Discussion

The actual concentrations of the AI in DPTs done at 30% of the commercially available form varied from 0.05% to 27.08% when tablets were used. Any report of the results of a DPT must give the exact concentration of the AI applied.

Conclusion

These data provide thresholds for the non-irritating concentration of 89 different drugs, and will help to standardize DPT methods.

Authors’ Affiliations

(1)
Department of Dermatology, Brabois Hospital, France
(2)
Department of Pharmacy, Brabois hospital, France

Copyright

© Brajon et al; licensee BioMed Central Ltd. 2014

This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.

Advertisement